Alert detail

LCD L37725: MolDX: Melanoma Risk Stratification Molecular Testing — Palmetto GBA

Policy ID: LCD-L37725Specialty: DermatologyAdded: 6/5/2026Effective: June 26, 2025lcd
High

What changed

Prepare for changes in melanoma risk testing reimbursements.

Who’s affected: Dermatology billing teams · Effective: June 26, 2025

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 9 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Dermatology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Dermatology audit pack — $349One-time purchase · not a subscription

Not ready to subscribe?

Get the free weekly reimbursement brief for Dermatology— the week’s changes and deadlines, delivered to your inbox. No account required.